Yan Wang

Title: Yan Wang: Innovator in Cancer Treatment

Introduction

Yan Wang is a prominent inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and inventions. With a total of 8 patents, her work focuses on advancing therapeutic methods for various cancers.

Latest Patents

One of her latest patents is titled "FDG-PET Evaluation of Ewing's Sarcoma Sensitivity." This invention relates to methods for evaluating the efficacy of an IGF1R inhibitor, such as an anti-IGF1R antibody, for the treatment of Ewing's sarcoma tumors. The method involves determining the level of tumoral glucose metabolism at an early point in the treatment regimen using techniques like FDG-PET/CT scans. Another notable patent is "Neutralizing Human Anti-IGFR Antibody," which includes fully human, neutralizing, monoclonal antibodies against the human Insulin-like Growth Factor Receptor-I (IGFR1). These antibodies are designed for treating or preventing cancer in subjects and encompass methods for their use and production.

Career Highlights

Throughout her career, Yan Wang has worked with reputable organizations, including Schering Corporation and Merck Sharp & Dohme Corporation. Her experience in these companies has allowed her to develop and refine her innovative ideas in the field of oncology.

Collaborations

Yan has collaborated with notable colleagues, including Jonathan A. Pachter and Robert Greenberg. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Yan Wang's contributions to cancer treatment through her patents and collaborations highlight her role as a leading innovator in the field. Her work continues to pave the way for new therapeutic approaches in oncology.